Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Gary Riordan, Kathy Surace-Smith, Michael Aicher

Premium

NanoString Technologies has appointed Gary Riordan as VP of quality and regulatory affairs and Kathy Surace-Smith as VP and general counsel.

Riordan formerly was VP of quality and regulatory affairs at Sequenom and director of regulatory affairs at Roche's Ventana Medical Systems.

Surace-Smith recently was VP and general counsel and corporate secretary of SonoSite, and she previously was VP and general counsel at Metawave Communications.


Ariosa Diagnostics has appointed Michael Aicher to its board of directors. He is currently the CEO of Omicia. Previously, he was co-founder and CEO of the National Genetics Institute, a wholly owned subsidiary of Laboratory Corporation of America.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.